Related Experiment Video
Updated: Mar 30, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
Oncogenic Ras suppresses ING4-TDG-Fas axis to promote apoptosis resistance
1Laboratory of Cancer Biology, Provincial Key Lab of Biotherapy in Zhejiang, Sir Runrun Shaw Hospital, Medical School of Zhejiang University, Hangzhou, China.
Abstract:
Ras is aberrantly activated in many cancers and active DNA demethylation plays a fundamental role to establish DNA methylation pattern which is of importance to cancer development. However, it was unknown whether and how Ras regulate DNA demethylation during carcinogenesis. Here we found that Ras downregulated thymine-DNA glycosylase (TDG), a DNA demethylation enzyme, by inhibiting the interaction of transcription activator ING4 with TDG promoter. TDG recruited histone lysine demethylase JMJD3 to the Fas promoter and activated its expression, thus restoring sensitivity to apoptosis. TDG suppressed in vivo tumorigenicity of xenograft pancreatic cancer. Thus, we speculate that reversing Ras-mediated ING4 inhibition to activate Fas expression is a potential therapeutic approach for Ras-driven cancers.
Insights
Ras activation in cancer suppresses thymine-DNA glycosylase (TDG) by inhibiting ING4. Restoring TDG reactivates Fas, restoring apoptosis sensitivity and suppressing pancreatic cancer growth.
Area of Science:
- Molecular oncology
- Epigenetics
- Cancer biology
Background:
- Aberrant Ras activation is common in many cancers.
- DNA demethylation is crucial for cancer development.
- The role of Ras in regulating DNA demethylation during carcinogenesis was unclear.
Purpose of the Study:
- To investigate the mechanism by which Ras regulates DNA demethylation in cancer.
- To explore the role of thymine-DNA glycosylase (TDG) in Ras-driven carcinogenesis.
Main Methods:
- Investigated Ras's effect on TDG expression and activity.
- Analyzed the interaction between ING4, TDG, and the TDG promoter.
- Examined TDG's role in recruiting JMJD3 to the Fas promoter.
- Assessed the impact of TDG on Fas expression and apoptosis sensitivity.
- Evaluated TDG's effect on xenograft pancreatic cancer tumorigenicity.
Main Results:
- Ras was found to downregulate thymine-DNA glycosylase (TDG).
- Ras inhibited the interaction between transcription activator ING4 and the TDG promoter.
- TDG recruited histone lysine demethylase JMJD3 to the Fas promoter, activating its expression.
- TDG restored sensitivity to apoptosis and suppressed in vivo tumorigenicity of xenograft pancreatic cancer.
Conclusions:
- Ras-mediated inhibition of ING4 suppresses TDG expression.
- Restoring TDG function can reactivate Fas expression and apoptosis.
- Targeting the Ras-ING4-TDG-Fas pathway may offer a therapeutic strategy for Ras-driven cancers.
More Related Videos
04:20Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
The Ras Gene
Ras is a...
The Intrinsic Apoptotic Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression